Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL
Clinical trial NCT02419560 · COMPLETED
Trial details
- NCT number
- NCT02419560
- Sponsor
- Craig Portell, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2021-05-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.